Incannex Completes Dosing in Phase 1 Clinical Trial to Assess Multi-Use, Anti-Inflammatory Drug IHL-675A; Proceeds to Phase 2 Clinical Trials
Incannex has today announced the completion of dosing of trial participants in a phase 1 clinical trial for arthritis using… Read more